Citalopram associated with acute angle-closure glaucoma: case report
- PMID: 16202173
- PMCID: PMC1262727
- DOI: 10.1186/1471-2415-5-23
Citalopram associated with acute angle-closure glaucoma: case report
Abstract
Background: Acute angle-closure glaucoma is a rare complication in patients receiving anti-depressant treatment. In the following case, we report the development of acute angle closure glaucoma in a patient who overdosed on Citalopram, an antidepressant, and discuss the possible etiological mechanisms for the condition.
Case presentation: We report a 54 year old, Caucasian lady, with depression and alcohol dependence syndrome, who developed acute angle-closure glaucoma after an overdose of Citalopram, along with alcohol. She was treated with medications and had bilateral Yag laser iridotomies to correct the glaucoma and has made complete recovery. In this case, the underlying cause for glaucoma appears to be related to the ingestion of Citalopram.
Conclusion: The patho-physiological basis for acute angle closure glaucoma in relation to antidepressant medications remains unclear. The authors suggest Citalopram may have a direct action on the Iris or Ciliary body muscle through serotonergic or anti-cholinergic mechanisms or both. This case highlights the importance of the awareness of the underlying risks, which may predispose an individual to develop acute angle-closure glaucoma, and reminds the clinicians the significance of history taking and examination of the eye before and after starting anti-depressants. This area needs to be further researched.
References
-
- Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshelman S, Wittchen H, Kendler KS. Lifetime and 12 month prevalence of DSM-3R psychiatric disorders in the united states. Archives of General Psychiatry. 1994;51:8–19. - PubMed
-
- Lonquist J, Sutonen H, Syvalahti E, Appleberg B, Koskinen T, Maninikko T, Mehtones OP, Narala M, Shiro S, Auvinen J. Antidepressant efficacy and quality of life in Depression: A double blind study with moclobomide and Fluoxetine. Acta Psychiatrica Scandinavia. 1994;89:363–9. - PubMed
-
- Stokes PE. Fluoxetine: A five-year review. clinical therapeutics. 1993;15:216–43. - PubMed
-
- Nemeroff CB. Paroxetine: An overview of the efficacy and safety of a new selective reuptake inhibitor in the treatment of depression. Journal of clinical Psychopharmacology. 1993;13:10S–17S. - PubMed
-
- Birley M, Moret C. Neurological mechanisms involved in antidepressant therapies. Clin Neuropharmacol. 1993;16:387–400. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
